Exelixis, Inc. (EXEL) Shareholders & Insider Trades

Executive TeamFinancialsSegmentsShareholders

Exelixis shareholders at a glance

The largest holder of Exelixis stock is BlackRock Advisors LLC, with 26.8 million shares (10.66% of the company), worth about $1.46 billion as of September 25, 2026. The 10 largest holders together own 51.2%.

In Q2 2026, 785 institutional holdings reports listed shares worth $14.40 billion.

Insiders reported 89 transactions in the last two years: 33 sales worth $63.41 million and 1 purchase. The newest one on file is from May 7, 2026 (Beckerle Mary C, Director).

Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through May 7, 2026.

EXEL logo

Exelixis, Inc.

EXELUnited States
Healthcare

Shareholders Summary

2026Q2

Filings
785
Options Value
$90.70M
Value (excl. Options)
$14.40B
Shares (excl. Options)
-

Ownership by Type

Geographic Distribution

Largest Exelixis shareholders

HolderShares% of companyValue
BlackRock Advisors LLC26.8 million10.66%$1.5B
Farallon Capital Management LLC14.0 million5.57%$764.0M
Farallon Capital Management LLC13.5 million5.36%$736.0M
Renaissance Technologies LLC13.4 million5.34%$734.0M
Vanguard Portfolio Management LLC12.0 million4.79%$658.0M
AQR Capital Management LLC11.0 million4.39%$602.0M
Vanguard Capital Management LLC11.0 million4.36%$598.0M
State Street Corporation10.0 million3.97%$545.0M
Fuller & Thaler Asset Management, Inc.8.9 million3.55%$488.0M
LSV Asset Management8.1 million3.24%$445.0M

As of September 25, 2026.

Exelixis institutional holdings by quarter

QuarterReportsSharesValue
Q2 2026785–$14.4B
Q1 2026723259.0 million$11.1B
Q4 2025714–$11.8B
Q3 2025657252.0 million$10.4B
Q2 2025663257.0 million$11.3B
Q1 2025588255.0 million$9.4B
Q4 2024548252.0 million$8.4B
Q3 2024490255.0 million$6.6B

Shares and value held by institutions that file quarterly holdings reports (options not included).

Exelixis insider trades

InsiderDateTitleTransactionValue
Beckerle Mary CMay 7, 2026DirectorSale at price 48.45 per share.$373,646
Freire Maria CMay 7, 2026DirectorSale at price 46.00 per share.$949,164
Poste George HMay 7, 2026DirectorSale at price 45.71 per share.$2.7M
Beckerle Mary CMay 7, 2026DirectorConversion of Exercise of derivative security at price 23.24 per share.$89,613
Freire Maria CMay 7, 2026DirectorConversion of Exercise of derivative security at price 19.77 per share.$407,934
Aftab T DanaFeb 26, 2026OfficerStock Award(Grant) at price 0.00 per share.–
Hefti BrendaFeb 26, 2026General CounselStock Award(Grant) at price 0.00 per share.–
Senner Christopher J.Feb 26, 2026Chief Financial OfficerStock Award(Grant) at price 0.00 per share.–
Haley Patrick JosephFeb 26, 2026OfficerStock Award(Grant) at price 0.00 per share.–
Morrissey Michael MFeb 26, 2026Chief Executive OfficerStock Award(Grant) at price 0.00 per share.–
Morrissey Michael MFeb 24, 2026Chief Executive OfficerStock Gift at price 0.00 per share.–
Aftab T DanaFeb 24, 2026OfficerSale at price 44.50 per share.$2.1M

Newest 12 of 89 insider transactions in the last two years.

Questions and answers

Who owns the most Exelixis stock?

BlackRock Advisors LLC, with 10.66% of the company (as of September 25, 2026). Next: Farallon Capital Management LLC (5.57%) and Farallon Capital Management LLC (5.36%).

How many institutions own Exelixis stock?

785 institutional holdings reports listed Exelixis shares in Q2 2026 worth $14.40 billion.

Are Exelixis insiders buying or selling the stock?

In the last two years insiders reported 33 sales and 1 purchase (89 transactions in all); the newest on file is from May 7, 2026.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
LinkedInLinkedInXXYouTubeYouTube